Stay updated on ALPN-303 Safety and Tolerability Clinical Trial
Sign up to get notified when there's something new on the ALPN-303 Safety and Tolerability Clinical Trial page.

Latest updates to the ALPN-303 Safety and Tolerability Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2; no substantive study details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedMinor revision update from v3.4.0 to v3.4.1. There are no substantive changes to the study details, eligibility criteria, or other user-facing content.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; there appear to be no changes to the study content, eligibility criteria, or other user-facing data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4. Core study content and user-facing information remain unchanged.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a Locations section with Queensland and Victoria (Australia) sites; revision updated to v3.3.3.SummaryDifference0.4%

Stay in the know with updates to ALPN-303 Safety and Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALPN-303 Safety and Tolerability Clinical Trial page.